Low Molecular Weight Nucleoside Gelators: A Platform for Protein Aggregation Inhibition.


Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
07 01 2019
Historique:
pubmed: 30 11 2018
medline: 19 11 2019
entrez: 30 11 2018
Statut: ppublish

Résumé

Low molecular weight nucleoside gelators hold great promise in drug delivery and particularly for the delivery of biologics because of their excellent biocompatibility. However, the influence of these gelators on protein aggregation inhibition has not yet been studied. Protein aggregation is the most significant cause of protein instability and can severely impact the biological activity of the protein, impairing the quality and safety of the formulation. Herein, we report the ability of a nucleoside-based gelator, N4-octanoyl-2'-deoxycytidine, to inhibit protein aggregation. Using turbidimetric, spectroscopic, and microscopic methods, we demonstrate that protein aggregation inhibition is dependent on gelator concentration. Moreover, we have found that the protein is still functionally active in the hydrogel.

Identifiants

pubmed: 30495960
doi: 10.1021/acs.molpharmaceut.8b01013
doi:

Substances chimiques

Nucleosides 0
Protein Aggregates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-467

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L013827/1
Pays : United Kingdom

Auteurs

Litty Johnson (L)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Maria Galini Faidra Angelerou (MG)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Bhanu Teja Surikutchi (BT)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Stephanie Allen (S)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Mischa Zelzer (M)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Maria Marlow (M)

School of Pharmacy , University of Nottingham , University Park Campus, Nottingham NG72RD , United Kingdom.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Administration, Intranasal Humans Animals Nasal Mucosa Brain
Humans Neoplasms Cell Membrane Inflammation Nanoparticles

Classifications MeSH